Siamed'Xpress Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • 2ndary - Private

Siamed'Xpress General Information

Description

Operator of bio-proteins platform intended for research, therapeutics, and diagnostics with serum-like glycosylation. The company's product is sialylated, serum-like, glycoproteins designed to make it possible to humanize the clones producing therapeutic proteins in order to prolong their activity, enabling healthcare professionals with the reduction of the doses injected and side effects.

Contact Information

Website
www.siamedxpress.com
Ownership Status
Privately Held (backing)
Financing Status
Formerly Accelerator/Incubator backed
Corporate Office
  • Hôtel Technologique Morandat
  • 1480 avenue d'Arménie
  • 13120 Gardanne
  • France
+33 04 00 00 00 00
Primary Industry
Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • Hôtel Technologique Morandat
  • 1480 avenue d'Arménie
  • 13120 Gardanne
  • France
+33 04 00 00 00 00

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Siamed'Xpress Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Secondary Transaction - Private 01-Sep-2023 0000 Completed Generating Revenue
2. Angel (individual) 13-Dec-2016 0000 0000 00000 Completed Generating Revenue
1. Accelerator/Incubator 21-May-2012 Completed Generating Revenue
To view Siamed'Xpress’s complete valuation and funding history, request access »

Siamed'Xpress Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Ordinary 0,000 000.000000 000.00 000.00 00 000.00 000
To view Siamed'Xpress’s complete cap table history, request access »

Siamed'Xpress Patents

  • 3

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 2

    Granted

  • 000

    Pending

  • 000

    Expiring in next 12 mo

Siamed'Xpress Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3019601-A1 Methods for producing sialylated therapeutic proteins Active 11-Jul-2013 0000000000
EP-3019601-B1 Methods for producing sialylated therapeutic proteins Active 11-Jul-2013 0000000000
EP-2824176-A1 Methods for producing sialylated therapeutic proteins Inactive 11-Jul-2013 C12P21/005 00

Siamed'Xpress Executive Team (1)

Name Title Board Seat
Catherine Ronin-Vaisse Ph.D Founder, Chief Executive Officer and President
To view Siamed'Xpress’s complete executive team members history, request access »

Ready to get started?

Request a free trial

Siamed'Xpress FAQs

  • When was Siamed'Xpress founded?

    Siamed'Xpress was founded in 2010.

  • Who is the founder of Siamed'Xpress?

    Catherine Ronin-Vaisse Ph.D is the founder of Siamed'Xpress.

  • Who is the CEO of Siamed'Xpress?

    Catherine Ronin-Vaisse Ph.D is the CEO of Siamed'Xpress.

  • Where is Siamed'Xpress headquartered?

    Siamed'Xpress is headquartered in Gardanne, France.

  • What industry is Siamed'Xpress in?

    Siamed'Xpress’s primary industry is Biotechnology.

  • Is Siamed'Xpress a private or public company?

    Siamed'Xpress is a Private company.

  • What is Siamed'Xpress’s current revenue?

    The current revenue for Siamed'Xpress is 000000.

  • How much funding has Siamed'Xpress raised over time?

    Siamed'Xpress has raised $88K.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »